| Margaret E Johnson Baylson, MD | |
|
51 North 39th St., 7 Floor-mutch Bldg., Philadelphia, PA 19104-2640 | |
| (215) 662-8777 | |
| (215) 243-3290 |
| Full Name | Margaret E Johnson Baylson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 51 North 39th St., Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255493607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD433340 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
In a recent study, Indian researchers from Midnapore City College, and Indian Center for Space Physics, looked at how the assembly elections conducted during the second wave of COVID-19 impacted the transmission of the infection - on the effective contact rate and the effective reproduction number of the SARS-CoV-2 virus. The study is published on the preprint server, medRxiv*.
Although cardiovascular disease risk prediction models are developed with predominantly white populations, application of models to a large black population finds that they work well in black individuals and are not easily improved on, suggesting that a unique risk calculator for black adults may not be necessary, according to a study published online by JAMA Cardiology.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has been granted Certificate of Good Manufacturing Practice (GMP) compliance for its cell therapy manufacturing facility in Besançon, France.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 2 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
In a recent study, Indian researchers from Midnapore City College, and Indian Center for Space Physics, looked at how the assembly elections conducted during the second wave of COVID-19 impacted the transmission of the infection - on the effective contact rate and the effective reproduction number of the SARS-CoV-2 virus. The study is published on the preprint server, medRxiv*.
Although cardiovascular disease risk prediction models are developed with predominantly white populations, application of models to a large black population finds that they work well in black individuals and are not easily improved on, suggesting that a unique risk calculator for black adults may not be necessary, according to a study published online by JAMA Cardiology.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has been granted Certificate of Good Manufacturing Practice (GMP) compliance for its cell therapy manufacturing facility in Besançon, France.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 2 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053447151 PECOS PAC ID: 6204730955 Enrollment ID: O20150304001436 |
News Archive
In a recent study, Indian researchers from Midnapore City College, and Indian Center for Space Physics, looked at how the assembly elections conducted during the second wave of COVID-19 impacted the transmission of the infection - on the effective contact rate and the effective reproduction number of the SARS-CoV-2 virus. The study is published on the preprint server, medRxiv*.
Although cardiovascular disease risk prediction models are developed with predominantly white populations, application of models to a large black population finds that they work well in black individuals and are not easily improved on, suggesting that a unique risk calculator for black adults may not be necessary, according to a study published online by JAMA Cardiology.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has been granted Certificate of Good Manufacturing Practice (GMP) compliance for its cell therapy manufacturing facility in Besançon, France.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret E Johnson Baylson, MD 51 N 39th St, 7 Floor - Mutch Bldg., Philadelphia, PA 19104-2640 Ph: (215) 662-8777 | Margaret E Johnson Baylson, MD 51 North 39th St., 7 Floor-mutch Bldg., Philadelphia, PA 19104-2640 Ph: (215) 662-8777 |
News Archive
In a recent study, Indian researchers from Midnapore City College, and Indian Center for Space Physics, looked at how the assembly elections conducted during the second wave of COVID-19 impacted the transmission of the infection - on the effective contact rate and the effective reproduction number of the SARS-CoV-2 virus. The study is published on the preprint server, medRxiv*.
Although cardiovascular disease risk prediction models are developed with predominantly white populations, application of models to a large black population finds that they work well in black individuals and are not easily improved on, suggesting that a unique risk calculator for black adults may not be necessary, according to a study published online by JAMA Cardiology.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has been granted Certificate of Good Manufacturing Practice (GMP) compliance for its cell therapy manufacturing facility in Besançon, France.
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
› Verified 2 days ago
Srikar Vegesna, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2118 Cottman Ave, Philadelphia, PA 19149 Phone: 215-342-3020 Fax: 215-342-3653 | |
Chelsea Tiffany Salas-tam, Family Medicine Medicare: Medicare Enrolled Practice Location: 833 Chestnut St Ste 301, Philadelphia, PA 19107 Phone: 215-955-7190 | |
Meng-chao Lee, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Central Ave Ste 104, Philadelphia, PA 19111 Phone: 215-742-0712 Fax: 215-742-5218 | |
Carol Bowes-lawlor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 E Chestnut Hill Ave, Philadelphia, PA 19118 Phone: 215-753-9080 Fax: 215-753-8830 | |
Dr. Seung Hee Hong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 150, Philadelphia, PA 19134 Phone: 215-926-3535 Fax: 215-926-3536 | |
Dr. Denise Hamilton Christian, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 251 E Bringhurst St, Philadelphia, PA 19144 Phone: 215-844-1020 Fax: 215-844-8147 | |
Mara Leyzin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8025 Castor Ave, Philadelphia, PA 19152 Phone: 215-745-9900 Fax: 215-745-9902 |